Why is Zenith Drugs falling/rising?

As of 21-Aug, Zenith Drugs Ltd is currently priced at 75.85, with no change in price, reflecting a flat movement of 0.00%. The stock has shown a strong performance over the past week, increasing by 17.96%, while it has also outperformed the benchmark Sensex, which rose by only 1.84%. However, despite this short-term gain, the stock has underperformed its sector today by 0.46%. The moving averages indicate that the stock is performing better than the 5-day, 20-day, 50-day, and 100-day averages, but it remains below the 200-day moving average. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 400% compared to the 5-day average, suggesting heightened interest in the stock.
In the broader market context, while Zenith Drugs has outperformed the Sensex in the short term, its year-to-date performance shows a decline of 6.13%, contrasting with the Sensex's gain of 6.09%. This indicates that while the stock may be experiencing a temporary rise, it has struggled over a longer time frame. The lack of available positive or negative factors in the dashboard limits a deeper analysis of the underlying reasons for the stock's recent movements. Overall, the stock's current flat price movement, combined with its recent strong weekly performance and increased trading activity, suggests a complex situation where short-term gains may not fully reflect its longer-term challenges.